kdigo controversies conference novel techniques and ... › wp-content › uploads › 2017 › 02...
TRANSCRIPT
-
Monitoring the Hemodialysis Dose
KDIGO Controversies ConferenceNovel techniques and innovation in blood purification:
How can we improve clinical outcomes in hemodialysis?October 14-15, 2011
Paris France
Monitoring the Hemodialysis Dose
Tom Depner, M.D.University of California, Davis
-
© 2001 By Default!Slide 2
Removal of accumulated smallsolutes is important
A Free sample background from www.pptbackgrounds.fsnet.co.uk
solutes is important
-
How long will I live if I choose to stop dialysis?
This varies from person to person. People who stop dialysis may live anywhere from who stop dialysis may live anywhere from one week to several weeks, depending on the amount of kidney function they have leftand their overall medical condition.
National Kidney Foundation web site
-
Art Buchwald
Famous as a syndicated humorist in life, after his death he is more notable for his reputation as the man who beat hospice and the kidney machine.
-
How long will I live if I choose to stop dialysis?
The median time to death after stopping The median time to death after stopping dialysis in a series of 18 patients reported by Rich was 7 days (0-17 days)
Rich A, Palliative Med 15:513-14, 2001.
-
The cause of death is uremia
� Principal cause: accumulation of toxic solutes normally excreted by the kidney
� Evidence: dialysis works by removing small solutes.solutes.
� Death is not due to anemia, vitamin D deficiency, hyperparathyroidism, fluid overload, accumulation of beta 2-microglobulin, etc, etc.
-
Minimum urea clearance for Hemodialysis
KDOQI guidelines call for a continuous equivalent Kt/Vurea of 2.0 volumes/week.
2.0 volumes per week x 35 L = 70 L/week
= 70,000 ml/L /10080 min/week
= 7 ml/min
-
© 2001 By Default!Slide 8
HEMO Study: Survival by Kt/V Group
A Free sample background from www.pptbackgrounds.fsnet.co.ukEknoyan et al, N Eng J Med 2002
-
3
4
5
6
7
We
ek
ly D
ialy
sis
Do
se
(s
tdK
t/V
)
6
Hemodialysissessions/wk
HEMO: High
DailyDialysis
Effect of Increasing Number of Effect of Increasing Number of Effect of Increasing Number of Effect of Increasing Number of Dialysis Sessions Per WeekDialysis Sessions Per WeekDialysis Sessions Per WeekDialysis Sessions Per Week
9
0.0 0.5 1.0 1.50
1
2
3
We
ek
ly D
ialy
sis
Do
se
(s
tdK
t/V
)
3
HEMO: Standard
Dialysis dose each dialysis (eKT/V)
7 ml/min
8 ml/min
-
Slide 10
Deficiencies of Kt/V
� Residual kidney function not considered
� Solute disequilibrium is under-represented
No provision for dialysis frequency� No provision for dialysis frequency
� K and t may not be equivalent
� V is independently associated with outcome
� Non-linear correlation with outcome
-
Effect of Kr-urea on mortality in HD patients
12
14
16
18
20
RR
mo
rta
lity
5.0 to 62.6
Adjustments: age, Adjustments: age, comorbidity score, comorbidity score, primary kidney primary kidney disease, SGA, BMIdisease, SGA, BMI
Termorshuizen F, et al: JASN 15:1061Termorshuizen F, et al: JASN 15:1061--70, 200470, 2004
0
2
4
6
8
10
RR
mo
rta
lity
0 0 to 0.84 >0.84
KrT/V per week
reference1.1 to 2.6
-
Slide 12
Deficiencies of Kt/V
� Residual kidney function not considered
� Solute disequilibrium is under-represented
No provision for dialysis frequency� No provision for dialysis frequency
� K and t may not be equivalent
� V is independently associated with outcome
� Non-linear correlation with outcome
-
Slide 15
Standard K (and Kt/V) - Gotch
continuous removal rate
average peak concentrationStandard K =
In a steady state, the removal rate is equal to the generation rate (G)
Standard K =G
average peak concentration
-
© 2001 By Default!Slide 16
Standard Kt/V
t
e110080
Kt/V
eKt/V−
=
−
A Free sample background from www.pptbackgrounds.fsnet.co.uk
1Nt
10080
eKt/V
e1tKt/V
eKt/Vstd
−+−
=−
Gotch, FA: Nephrol Dial Transplant 13 Suppl 6:10-14, 1998
Leypoldt, JK: Seminars In Dialysis 17:142-145, 2004
-
© 2001 By Default!Slide 17
Standard Kt/V adjusted for Uf and Kru
stdKt/V = S/[1 - (0.74/F) • Uf/V]
+ Kru • [0.974/(spKt/V + 1.62) + 0.4] • 10/V
A Free sample background from www.pptbackgrounds.fsnet.co.ukDaugirdas J, et al: Kidney Int 2010
S is the unadjusted stdKt/V per week
F is the number of dialyses/week
Uf is the weekly fluid removal in liters
Kru is the residual native kidney clearance of urea in ml/min
spKt/V is the single pool Kt/V per dialysis
V is the urea distribution volume in liters
-
4.0
5.0
6.0
7.0S
tandard
Kt/
VContinuous vs. intermittent clearance expressions
7/week
6
5
4
per
week
0.00 0.50 1.00 1.50 2.00 2.50
spKt/V per dialysis
0.0
1.0
2.0
3.0
Sta
ndard
Kt/
V
3
2
1
per
week
-
© 2001 By Default!Slide 19
4.0
5.0
6.0
7.0R
e-d
efin
ed
Kt/
V (
pe
r w
ee
k)
Continuous versus peak concentration methods
Mean methodPeak method
7/week
6
5
4
A Free sample background from www.pptbackgrounds.fsnet.co.uk
0.00 0.50 1.00 1.50 2.00 2.50
spKt/V per dialysis
0.0
1.0
2.0
3.0
Re
-de
fin
ed
Kt/
V (
pe
r w
ee
k)
3
2
1
-
Slide 20
Deficiencies of Kt/V
� Residual kidney function not considered
� Solute disequilibrium is under-represented
No provision for dialysis frequency� No provision for dialysis frequency
� K and t may not be equivalent
� V is independently associated with outcome
� Non-linear correlation with outcome
-
© 2001 By Default!Slide 21
0.90
1.00
1.10
1.20K
t/V
Effect of treatment time on eKt/V
eKt/V1.09
spKt/V
A Free sample background from www.pptbackgrounds.fsnet.co.uk
2 4 6 8 10
Td (treatment time in hours)
0.60
0.70
0.80
0.90
Kt/V
0.87
-
Treatment time predicts mortalitySaran et al from DOPPS, Kid Int 69:1222-28, 2006
New NKF-KDOQI Hemodialysis Guidelines
-
© 2001 By Default!Slide 23
1.20
1.40
Rela
tive R
isk o
f death
Mortality and Body Mass IndexUSRDS: 3607 patients enrolled in CMAS, Jan 1991
ad
juste
d f
or
ag
e,
se
x,
race
& o
the
r fa
cto
rs
quintile means ñ 95% confidence intervals
A Free sample background from www.pptbackgrounds.fsnet.co.uk
15 20 25 30 35 40 45
BMI
0.80
1.00
Rela
tive R
isk o
f death
Source: Leavey et al, AJKD 31:1002, 1998
ad
juste
d f
or
ag
e,
se
x,
race
& o
the
r fa
cto
rs
-
© 2001 By Default!Slide 24
Kurea•t
A Free sample background from www.pptbackgrounds.fsnet.co.uk
urea
Vurea
-
© 2001 By Default!Slide 25
Continuous risk (hazard) plane for Ktand BSA. The analysis did not include an inter-action term between Kt and BSA and was case mix adjusted.
43,334 patients
A Free sample background from www.pptbackgrounds.fsnet.co.uk
Continuous risk (hazard) plane for Ktand BSA. The analysis included an interactionterm between Kt and BMI and was case mixadjusted.
Lowrie E, et al: KI 62:1891-7, 2002
-
Slide 26
Deficiencies of Kt/V
� Residual kidney function not considered
� Solute disequilibrium is under-represented
No provision for dialysis frequency� No provision for dialysis frequency
� K and t may not be equivalent
� V is independently associated with outcome
� Non-linear correlation with outcome
-
0.6
0.8
1.0R
esponse (
R)
Concentration (Dose) - Response CurveHill equation: applies to a direct reversible effect
(1/Q) + CSCS
R =
0.5 1.0 10.0
Concentration (C in arbitrary units)
0.0
0.2
0.4
Response (
R)
-
6.0
8.0
10.0C
on
ce
ntr
atio
n (
C in
arb
itra
ry u
nits) Concentration versus Clearance
C = 1/K
0.0 0.2 0.4 0.6 0.8 1.0
Clearance (K) in arbitrary units)
0.0
2.0
4.0
Co
nce
ntr
atio
n (
C in
arb
itra
ry u
nits)
-
2
2.5
3
3.5
4
4.5
5
0
0.5
1
1.5
2
0 5 10 15 20
Steady-state solute concentration
-
Some proposed improvements to Kt/V
• Include residual native kidney clearance (Kr)
• Account for solute disequilibrium» eKt/V
• Allow for more frequent dialysis» Standardized Kt/V
• Index to surface area instead of V
• Tighter correlation with outcome» reciprocal of Kt/V
-
© 2001 By Default!Slide 31
Summary: uremia is a complex state
Comorbidity (DM, CVD, nutrition, anemia, etc)Comorbidity (DM, CVD, nutrition, anemia, etc)
Residual Syndrome:Residual Syndrome:
Slowly accumulating solutes:Slowly accumulating solutes:•• B2B2--microglobulin & other peptidesmicroglobulin & other peptides•• Calcium & phosphate depositsCalcium & phosphate deposits•• ProteinProtein--bound toxins?bound toxins?
Comorbidity (DM, CVD, nutrition, anemia, etc)
Residual Syndrome:
Slowly accumulating solutes:• B2-microglobulin & other peptides• Calcium & phosphate deposits• Protein-bound toxins?
A Free sample background from www.pptbackgrounds.fsnet.co.uk
Life threatening toxins
•• ProteinProtein--bound toxins?bound toxins?•• AGE’s ?AGE’s ?•• Carbamylated proteins ?Carbamylated proteins ?
Toxic effect of dialysis Toxic effect of dialysis -- exposure to exposure to membrane, hemodynamic effectsmembrane, hemodynamic effects
• Protein-bound toxins?• AGE’s ?• Carbamylated proteins ?
Toxic effect of dialysis - exposure to membrane, hemodynamic effects
-
© 2001 By Default!Slide 32
Future of dose monitoring
Because control of small solute concentrations
must be the principal goal of replacement
therapy, future efforts should focus not on
A Free sample background from www.pptbackgrounds.fsnet.co.uk
therapy, future efforts should focus not on
whether we should measure small solute
clearance, but what else we should measure
and do for our patients.
-
Adequacy of Dialysis
= Removal of Toxins
= Prevention of Uremia= Prevention of Uremia
= Restoration of Health